Comments
Loading...

LifeMD

LFMDNASDAQ
Logo brought to you by Benzinga Data
$5.16
0.000.00%
Pre-Market: 4:00 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$15.00
Lowest Price Target1
$7.00
Consensus Price Target1
$11.75

LifeMD (NASDAQ:LFMD) Stock, Analyst Ratings, Price Targets, Forecasts

LifeMD Inc has a consensus price target of $11.75 based on the ratings of 8 analysts. The high is $15 issued by Cantor Fitzgerald on September 20, 2024. The low is $7 issued by Keybanc on January 8, 2025. The 3 most-recent analyst ratings were released by Keybanc, Lake Street, and Mizuho on January 8, 2025, December 10, 2024, and December 4, 2024, respectively. With an average price target of $8.67 between Keybanc, Lake Street, and Mizuho, there's an implied 67.96% upside for LifeMD Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Aug 24
1
Sep 24
1
Nov 24
1
1
Dec 24
1
Jan
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Keybanc
Lake Street
Mizuho
HC Wainwright & Co.
Cantor Fitzgerald

1calculated from analyst ratings

Analyst Ratings for LifeMD

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for LifeMD (LFMD) stock?

A

The latest price target for LifeMD (NASDAQ:LFMD) was reported by Keybanc on January 8, 2025. The analyst firm set a price target for $7.00 expecting LFMD to rise to within 12 months (a possible 35.66% upside). 18 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for LifeMD (LFMD)?

A

The latest analyst rating for LifeMD (NASDAQ:LFMD) was provided by Keybanc, and LifeMD maintained their overweight rating.

Q

When was the last upgrade for LifeMD (LFMD)?

A

There is no last upgrade for LifeMD

Q

When was the last downgrade for LifeMD (LFMD)?

A

There is no last downgrade for LifeMD.

Q

When is the next analyst rating going to be posted or updated for LifeMD (LFMD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of LifeMD, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for LifeMD was filed on January 8, 2025 so you should expect the next rating to be made available sometime around January 8, 2026.

Q

Is the Analyst Rating LifeMD (LFMD) correct?

A

While ratings are subjective and will change, the latest LifeMD (LFMD) rating was a maintained with a price target of $10.00 to $7.00. The current price LifeMD (LFMD) is trading at is $5.16, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch